Rosen Law Firm sets Aug. 17 deadline in Embecta securities class action
Rosen Law Firm says Embecta Corp. common-stock purchasers between Nov. 25, 2025 and May 4, 2026 may seek lead-plaintiff status in a securities class action.
Rosen Law Firm said Aug. 2 that investors who bought Embecta Corp. common stock between Nov. 25, 2025, and May 4, 2026, may be eligible to take part in a securities class action tied to the company’s fiscal results.
The notice said a lawsuit has already been filed and that anyone seeking to serve as lead plaintiff must move the court by Aug. 17, 2026. It said investors may be able to join the case without paying out-of-pocket fees or costs through a contingency fee arrangement.
The notice says the case centers on allegations that Embecta made false and/or misleading statements or concealed material adverse facts about its fiscal results. It says the company allegedly knew or recklessly disregarded that its guidance was misleading and unattainable.
According to the notice, Embecta described its pen needle business as “incredibly resolute” before missing expectations and cutting 2026 fiscal guidance. The notice says investors suffered damages when the true details entered the market.
The notice also says no class has been certified yet. It said an investor can remain an absent class member and do nothing for now if they choose.
Embecta is identified in the notice as Nasdaq-listed under EMBC. The notice gives investors a way to join the action at rosenlegal.com/cases/embecta-corp/join and lists Phillip Kim, Esq. as a contact at 866-767-3653 and [email protected].
The notice was published as a PR Newswire release from Rosen Law Firm on Aug. 2, 2026. It sets Aug. 17, 2026, as the deadline for any investor seeking lead-plaintiff status.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
View the Web StoryA visual, tap-through version of this reportThis is the AMP version of the article. Read the full article on Atlas Watchline.